150 related articles for article (PubMed ID: 34975217)
1. Identification of the interleukin-8 (CXCL-8) pathway in feline oral squamous cell carcinoma - A pilot study.
Ackerman LH; de Mello Souza CH; Cortés-Hinojosa G; Salute ME; Stephen AA; Anthony E; Shiomitsu K; Milner RJ
Can J Vet Res; 2022 Jan; 86(1):13-19. PubMed ID: 34975217
[TBL] [Abstract][Full Text] [Related]
2. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical Features of Epithelial-Mesenchymal Transition in Feline Oral Squamous Cell Carcinoma.
Harris K; Gelberg HB; Kiupel M; Helfand SC
Vet Pathol; 2019 Nov; 56(6):826-839. PubMed ID: 31331247
[TBL] [Abstract][Full Text] [Related]
4. STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma.
Naher L; Kiyoshima T; Kobayashi I; Wada H; Nagata K; Fujiwara H; Ookuma YF; Ozeki S; Nakamura S; Sakai H
Int J Oncol; 2012 Nov; 41(5):1577-86. PubMed ID: 22922995
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody cetuximab impairs matrix metalloproteinases 2 and 9, epithelial-mesenchymal transition and cell migration in feline oral squamous cell carcinoma in vitro.
Altamura G; Martano M; Matrone A; Corteggio A; Borzacchiello G
Vet Comp Oncol; 2024 Mar; 22(1):149-155. PubMed ID: 38030131
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
7. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma.
Martin CK; Dirksen WP; Shu ST; Werbeck JL; Thudi NK; Yamaguchi M; Wolfe TD; Heller KN; Rosol TJ
Oral Oncol; 2012 Jun; 48(6):491-9. PubMed ID: 22265717
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid synthase as a potential therapeutic target in feline oral squamous cell carcinoma.
Walz JZ; Saha J; Arora A; Khammanivong A; O'Sullivan MG; Dickerson EB
Vet Comp Oncol; 2018 Mar; 16(1):E99-E108. PubMed ID: 28871635
[TBL] [Abstract][Full Text] [Related]
10. Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells.
Huang WL; Yeh HH; Lin CC; Lai WW; Chang JY; Chang WT; Su WC
Mol Cancer; 2010 Dec; 9():309. PubMed ID: 21122157
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of interleukin 8/C‑X-C chemokine receptor 1,/2 signaling reduces malignant features in human pancreatic cancer cells.
Fu S; Chen X; Lin HJ; Lin J
Int J Oncol; 2018 Jul; 53(1):349-357. PubMed ID: 29749433
[TBL] [Abstract][Full Text] [Related]
12. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway.
Yeh M; Gharavi NM; Choi J; Hsieh X; Reed E; Mouillesseaux KP; Cole AL; Reddy ST; Berliner JA
J Biol Chem; 2004 Jul; 279(29):30175-81. PubMed ID: 15143062
[TBL] [Abstract][Full Text] [Related]
13. Histologic, immunohistochemical, and in situ hybridization study of myxoid stroma in feline oral squamous cell carcinoma.
Mineshige T; Tanaka Y; Watanabe K; Tagawa M; Tomihari M; Kobayashi Y
J Vet Med Sci; 2024 Mar; 86(3):258-265. PubMed ID: 38233195
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation.
Kurago ZB; Lam-ubol A; Stetsenko A; De La Mater C; Chen Y; Dawson DV
Head Neck Pathol; 2008 Mar; 2(1):1-12. PubMed ID: 19603082
[TBL] [Abstract][Full Text] [Related]
15. [Angiotensin converting enzyme 2 alleviates infectious bronchitis virus-induced cellular inflammation by suppressing IL-6/JAK2/STAT3 signaling pathway].
Ji X; Wang H; Ma C; Li Z; DU X; Zhang Y
Sheng Wu Gong Cheng Xue Bao; 2023 Jul; 39(7):2669-2683. PubMed ID: 37584123
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell-derived IL-8 induces monocytic THP1 cells to secrete IL-8 via the mitogen-activated protein kinase pathway.
Nishio Y; Gojoubori T; Kaneko Y; Shimizu N; Asano M
Tumour Biol; 2015 Dec; 36(12):9171-7. PubMed ID: 26088451
[TBL] [Abstract][Full Text] [Related]
17. 5-lipoxygenase expression and tepoxalin-induced cell death in squamous cell carcinomas in cats.
Wakshlag JJ; Peters-Kennedy J; Bushey JJ; Loftus JP
Am J Vet Res; 2011 Oct; 72(10):1369-77. PubMed ID: 21962280
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of cats.
Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K
Am J Vet Res; 2017 Aug; 78(8):946-953. PubMed ID: 28738012
[TBL] [Abstract][Full Text] [Related]
20. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
